View and Policy on Reduction of Investment Unit
Filed with TSE · · 1 page · English
August 28, 2026 Company name: COSMOS Pharmaceutical Corporation Name of representative: Hideaki Yokoyama, President (Securities code: 3349; TSE Prime Market) Contact: Motoi Takemori, Director and Corporate Planning Department Manager (Phone: +81-92-433-0660) View and Policy on Reduction of Investment Unit 1. View on reduction of investment unit COSMOS Pharmaceutical Corporation (the “Company”) rec
COSMOS Pharmaceutical Corporation on 6ix
Earlier from COSMOS Pharmaceutical
- Notice Concerning Changes in Directors
- Consolidated Financial Results for the Fiscal Year Ended May 31, 2026[Japanese GAAP]
- COSMOS Pharmaceutical: Consolidated Financial Results for the Fiscal Year Ended May 31, 2022
Later from COSMOS Pharmaceutical
All COSMOS Pharmaceutical news releasesFollow COSMOS Pharmaceutical into a list and get an email when it puts out news.
Follow COSMOS Pharmaceutical